✓ Betalning med kreditkort återställd — säker kassahantering via Privacy Shield

Lamivir Hbv

Lamivir HBV (Lamivudine 100 mg) — Cipla older HBV monotherapy. Modern guidelines prefer entecavir or tenofovir for first-line treatment due to higher resistance with prolonged lamivudine.

Artikelnummer: Lamivir Hbv Kategori: , , ,

Medicinskt granskad av Morgan Ellis — Apoteksforskare · 8 års erfarenhet  · Senast granskad: maj 2026

Krypterad kassa
Kryptobetalning ger 10% rabatt
Diskret världsomspännande leverans
1 400+ kunder · 50+ länder

Denna produkt är för närvarande slut i lager och inte tillgänglig.

Quick Answer

Lamivir HBV — Lamivudine 100 mg (Cipla Inc). Lamivudine 100 mg once daily for chronic hepatitis B virus suppression. Older HBV monotherapy; modern guidelines prefer entecavir or tenofovir for first-line due to lower resistance.

Vad du får med MedsBase:

  • WHO-GMP-certifierad tillverkare
  • Diskret förpackning i vanligt kuvert
  • Världsvid leverans
  • Betygsatt av 1 400+ kunder (läs recensioner)

📦 Reshipment Assurance: om din order inte har anlänt 20 arbetsdagar efter försändelse, skickar vi en ny utan extra kostnad. Läs policyn.

Varför beställa från MedsBase

Lamivir HBV ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.

HIV testing essential
Lamivudine and entecavir as monotherapy in untreated HIV/HBV co-infection rapidly select HIV resistance (M184V for lamivudine; integrase mutations for entecavir). Test HIV before starting any HBV monotherapy. If HIV-positive, use a complete ART regimen that covers both viruses (typically TDF or TAF + emtricitabine/lamivudine + third agent).
Stopping risk
Abrupt withdrawal of any anti-HBV nucleoside/nucleotide can cause severe acute HBV flare with possible decompensation. Never stop without hepatology supervision and post-stop monitoring.

Vanliga frågor

When is monotherapy appropriate?

Lamivudine HBV monotherapy is largely outdated due to resistance development. Entecavir and tenofovir are first-line. Lamivudine remains an option in resource-limited settings, in pregnancy (extensive safety data), or as part of combination therapy.

Cure for HBV?

True cure (HBsAg loss, sometimes called functional cure) is rare with current oral therapy — typically <5% per year. Most patients need long-term/lifelong suppression. Disease activity, fibrosis, and HCC risk reduce dramatically with consistent therapy even without HBsAg clearance.

When can I stop?

Cessation is considered after sustained HBeAg seroconversion + undetectable HBV DNA for ≥12 months in HBeAg-positive disease, or HBsAg loss. Discontinuation should always be specialist-supervised with close monitoring for HBV flare.

HCC monitoring?

All patients with chronic HBV need 6-monthly HCC surveillance with abdominal ultrasound ± AFP, especially if cirrhotic, family history of HCC, or specific demographics (Asian male >40, African >20, persistent inflammation).

Graviditet?

Tenofovir is preferred for pregnancy (TDF or TAF). Lamivudine is alternative with extensive pregnancy data. Entecavir is generally avoided due to limited pregnancy data.

Läkemedelsinteraktioner?

Few major interactions for these renally cleared drugs. Avoid combination with nephrotoxic drugs (NSAIDs chronic, aminoglycosides). Tenofovir + ledipasvir-containing Hep C regimens — monitor renal function.

Vad händer om jag missar en dos?

Take when you remember if same day; if next day, skip the missed dose. Do not double up. Discuss adherence challenges with your hepatologist — alternative regimens or simplified dosing may be available.

Side effects?

Generally well tolerated. Tenofovir disoproxil: renal tubulopathy, bone density loss long-term. Tenofovir alafenamide: minimal renal/bone impact. Entecavir: rare lactic acidosis. Lamivudine: very well tolerated.

What about HCC after treatment?

HBV-related HCC risk persists even after viral suppression — never stop surveillance just because HBV DNA is undetectable. Cirrhotic patients especially need lifelong 6-monthly USS.

Vaccination?

All household contacts and sexual partners should be tested for HBsAg and HBV-vaccinated if susceptible. Patient should also receive HAV vaccination, pneumococcal, annual influenza, and (after CD4 recovery if HIV co-infected) other indicated vaccines.

Other Antiviral Medications

  • Tenvir L — tenofovir + lamivudine — combined HIV/HBV NRTI backbone
  • X-Vir — entecavir 0.5/1 mg — first-line HBV monotherapy
  • Lamivir HBV — lamivudine 100 mg — older HBV monotherapy
  • MyHep — sofosbuvir 400 mg — for HCV
  • Zimivir — valacyclovir 500/1000 mg — for HSV
Medicinsk ansvarsfriskrivning: HIV treatment is a complex, lifelong therapy. Drug choice depends on genotype, resistance testing, comorbidities, and prior treatment history. Discuss any regimen change with an HIV specialist. Adherence >95% is required to prevent resistance. Test for HBV before starting any tenofovir-, lamivudine-, or emtricitabine-containing regimen — withdrawal can cause severe HBV flare in co-infected patients.

More options in Hepatitis Medication

Rangerade efter senaste ordervolym på MedsBase — vad andra kunder i denna kategori väljer.

Styrka

100 mg

Kvantitet

30 Tablett/er, 60 Tablett/er, 90 Tablett/er

Farmaceutisk form

Tabletter

Tillverkare

Cipla Inc

Behandling

HIV Infection

Generiskt märke

Lamivudine

Recensioner

Det finns inga recensioner än

Skriv en recension
Lamivir Hbv Lamivir Hbv
Betyg*
0/5
* Betyg är obligatoriskt
* Svar är obligatoriskt
Din recension
* Recension är obligatorisk
Namn
* Namn är obligatoriskt
Lägg till foton eller video i din recension

Frågor & svar

Ställ en fråga
Lamivir Hbv Lamivir Hbv
Din fråga
* Fråga är obligatorisk
Namn
* Namn är obligatoriskt
Det finns inga frågor än